Beneficial effects of erythropoietin in models of shock and organ failure-nothing is simple and easy.
Simon
Florian
F
Calzia
Enrico
E
Radermacher
Peter
P
Schelzig
Hubert
H
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000975:Antioxidants / Q000378:metabolism; D017209:Apoptosis; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D009102:Multiple Organ Failure / Q000188:drug therapy*; D018384:Oxidative Stress; D011994:Recombinant Proteins / Q000378:metabolism; D012769:Shock / Q000188:drug therapy*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa